InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
5
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Bischofberger Norbert W, 董事长兼首席执行官. Officer active across 2 companies, notably Kronos Bio, Inc.. Aggregated, 11 disclosures have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €3.1m. Activity tracked since 6 December 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bischofberger Norbert W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
8,000 股0Common StockSEC:0001628280-26-038961:0
10,802,138 股@ US$0.5763.6% 占其流量Common StockSEC:0001415889-25-017836:0
10,667 股0Common StockSEC:0001628280-25-030078:0
8,000 股0Common StockSEC:0001628280-25-028888:0
410,848 股@ US$1.165513.9% 占其流量Common StockSEC:0001415889-24-018703:0
标准退出：2024年9月25日 (T+90)
1,378,901 股@ US$0.876434.9% 占其流量Common StockSEC:0001415889-24-016563:0
标准退出：2024年9月8日 (T+90)
16,000 股0Common StockSEC:0001628280-24-025997:0
270,339 股0Common StockSEC:0001415889-24-004262:0
1,370,688 股@ US$0.804531.5% 占其流量Common StockSEC:0001209191-23-055826:0
标准退出：2024年2月13日 (T+90)
90,931 股@ US$3.83293.9% 占其流量Common StockSEC:0001209191-22-030688:0
标准退出：2022年8月15日 (T+90)
14,356 股@ US$12.0851.8% 占其流量Common StockSEC:0001209191-21-068594:0
标准退出：2022年3月6日 (T+90)
11 条申报中的 11 条
About Bischofberger Norbert W
BISCHOFBERGER NORBERT W is Chief Executive Officer and Chairman. He has 11 filings in total. Across the 11 most recent sampled filings, they cover the period from 2021-12-08 to 2026-05-28, with EUR 3,067,410 of purchases and EUR 0 of sales, and the most common transaction nature is Acquisition. His filings concern Kronos Bio, Inc. and Vir Biotechnology, Inc., with several filings for Kronos Bio, Inc.
